Research Articles | Page 4 | Aplastic Anemia & MDS International Foundation

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Research Articles

Article Title Original Publication Date Journal Bone Marrow Disease
Calculator-free point-of-care prognostication in myelodysplastic syndromes. Jan 2019 Am J Hematol myelodysplastic syndromes (MDS)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia Jan 2019 Biol Blood Marrow Transplant aplastic anemia
Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis. Jan 2019 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. Jan 2019 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry Jan 2019 Am J Hematol aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial. Dec 2018 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria. Nov 2018 Hematology Am Soc Hematol Educ Program paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications. Oct 2018 Curr Oncol myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)